Discover the Tropocells® PRP Advantage

The Tropocells® PRP preparation system is designed to help clinicians prepare platelet-rich plasma (PRP) using a consistent, point-of-care workflow.

In addition, published research—including the Kushida study—has evaluated platelet concentration, growth factor levels, and cellular composition across multiple PRP systems.

Below is a summary of key characteristics associated with the Tropocells® system.

Key Features of the Tropocells® PRP Preparation System

High Platelet Concentration

First, the Tropocells® system is designed to concentrate platelets relative to baseline blood levels.

In the Kushida study, this system demonstrated approximately a threefold increase in platelet concentration, which aligns with commonly reported PRP preparation ranges in the literature.

Growth Factor Profile

In addition, PRP prepared using Tropocells® has been analyzed for platelet-associated proteins, including:

• Platelet-Derived Growth Factor (PDGF-AB)
• Transforming Growth Factor-Beta 1 (TGF-β1)
• Vascular Endothelial Growth Factor (VEGF)

These proteins are widely studied in research related to cell signaling, tissue biology, and angiogenesis.

Low Red Blood Cell (RBC) Content

Furthermore, the Tropocells® system is designed to reduce red blood cell (RBC) content during preparation.

Lower RBC levels are often discussed in the literature when evaluating PRP composition and inflammatory signaling environments.

Closed-System PRP Preparation

The Tropocells® system uses closed-system gel separation technology.

As a result, clinicians can process PRP within a controlled, sterile workflow that supports:

• consistent sample handling
• reduced contamination risk
• simplified in-office preparation

Practical and Cost-Conscious Design

Finally, the system is designed with clinical workflow efficiency in mind.

Therefore, many practices evaluate Tropocells® for its balance of:

• ease of use
• reproducibility
• operational efficiency

Tropocells® PRP FAQs

What makes the Tropocells® PRP system different?

The Tropocells® PRP preparation system is designed to produce platelet-rich plasma with:

• concentrated platelets
• measurable growth factor levels
• reduced red blood cell content

However, PRP composition may vary depending on preparation protocols and clinical handling.

How does Tropocells® support platelet concentration?

The system uses centrifugation and gel separation technology.

As a result, it helps separate platelets from other blood components and supports consistent platelet concentration during preparation.

Why are growth factors important in PRP research?

Platelets contain signaling proteins such as PDGF, TGF-β1, and VEGF.

These proteins are commonly studied in laboratory and clinical research related to:

• cellular communication
• angiogenesis
• tissue biology

How does Tropocells® reduce RBC content?

The system uses a specialized separation process designed to isolate plasma layers while limiting red blood cell carryover.

Therefore, clinicians can produce PRP with lower RBC levels compared to whole blood.

Is Tropocells® cost-effective for medical practices?

Many practices evaluate Tropocells® based on its workflow efficiency and system design.

In addition, the closed-system format helps support consistency and ease of use in clinical environments.

What types of practices use PRP preparation systems?

Clinicians may evaluate PRP preparation systems in:

• orthopedic and sports medicine practices
• pain management clinics
• regenerative medicine practices
• veterinary medicine settings

However, the clinical use of PRP is determined by the treating physician.

Is there published research on Tropocells®?

Yes. The Kushida study evaluated platelet and growth factor concentrations across seven commercial PRP systems, including Tropocells®.

The study reported differences in:

• platelet concentration
• growth factor levels
• cellular composition

However, results may vary depending on preparation methods and study conditions.

Summary of Kushida Study Findings

The Kushida study provides a comparative analysis of PRP preparation systems.

Key observations related to Tropocells® include:

• increased platelet concentration relative to baseline
• measurable levels of platelet-associated growth factors
• reduced red blood cell content compared to some systems
• consistent separation using a closed-system design

Importantly, PRP preparation results can vary based on system use, centrifugation protocols, and operator technique.

Clinical Considerations

When evaluating a PRP preparation system, clinicians often consider:

• platelet concentration levels
• leukocyte and RBC content
• reproducibility of preparation protocols
• workflow integration within the practice

Because of variability across systems, many researchers recommend standardized reporting of PRP preparation methods.

Regulatory Notice

Tropocells® systems are intended for the preparation of autologous platelet-rich plasma.

The clinical use of PRP is determined by the treating physician based on patient evaluation and professional judgment.

Statements regarding biological characteristics reflect published scientific literature and are not intended to imply FDA-cleared indications for specific clinical outcomes.

Reference

Kushida S, Kakudo N, Morimoto N, et al.
Platelet and growth factor concentrations in activated platelet-rich plasma: A comparison of seven commercial separation systems.
Journal of Artificial Organs. 2014.

PubMed: https://pubmed.ncbi.nlm.nih.gov/24748436/

Request More Information

To learn more about the Tropocells® PRP preparation system, contact Transcend Biologics:

📞 833-713-3414
📧 sales@transcendbiologics.com

Our team can provide:

• product information
• clinical workflow guidance
• training resources
• study summaries and documentation